Erik Lonnblom

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Protective and Pathogenic Antibodies to Citrullinated Antigens.

Protective and Pathogenic Antibodies to Citrullinated Antigens.

Journal: Immunological reviews

Published: June 22, 2026

Autoantibodies to Joint-Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals.

Autoantibodies to Joint-Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 05, 2025

Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis.

Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: December 20, 2024

Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritis.

Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: April 17, 2024

Correction: Antigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice.

Correction: Antigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice.

Journal: The Journal of experimental medicine

Published: October 03, 2023

A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils.

A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils.

Journal: Nature communications

Published: April 17, 2023

Antigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice.

Antigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice.

Journal: The Journal of experimental medicine

Published: January 16, 2023

Pathogenic antibody response to glucose-6-phosphate isomerase targets a modified epitope uniquely exposed on joint cartilage.

Pathogenic antibody response to glucose-6-phosphate isomerase targets a modified epitope uniquely exposed on joint cartilage.

Journal: Annals of the rheumatic diseases

Published: November 16, 2022

A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis.

A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis.

Journal: Nature communications

Published: September 12, 2022

Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage.

Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage.

Journal: Arthritis research & therapy

Published: August 28, 2022

Autoantibodies to Disease-Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid Arthritis.

Autoantibodies to Disease-Related Proteins in Joints as Novel Biomarkers for the Diagnosis of Rheumatoid Arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 11, 2022

Early Increase of Circulating Transitional B Cells and Autoantibodies to Joint-Related Proteins in Patients With Metastatic Melanoma Developing Checkpoint Inhibitor-Induced Inflammatory Arthritis.

Early Increase of Circulating Transitional B Cells and Autoantibodies to Joint-Related Proteins in Patients With Metastatic Melanoma Developing Checkpoint Inhibitor-Induced Inflammatory Arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 30, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026